Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Nektar Therapeutics - Common Stock
(NQ:
NKTR
)
69.39
-1.26 (-1.78%)
Streaming Delayed Price
Updated: 12:16 PM EDT, Sep 11, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Nektar Therapeutics - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Nektar Therapeutics's Earnings: A Preview
↗
May 07, 2025
Via
Benzinga
Assessing Nektar Therapeutics: Insights From 5 Financial Analysts
↗
April 11, 2025
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
↗
March 14, 2025
Via
Benzinga
Assessing Nektar Therapeutics: Insights From 4 Financial Analysts
↗
March 13, 2025
Via
Benzinga
Top movers in Friday's after hours session
↗
February 21, 2025
As the regular session of the US market concludes on Friday, let's get an insight into the after-hours session and identify the stocks leading the pack in terms of gains and losses.
Via
Chartmill
Sweet Nektar?
↗
April 22, 2024
NKTR has had a terrible time of it for years, but maybe it’s finally ready to turn around.
Via
Talk Markets
Nektar Therapeutics Earnings Preview
↗
March 01, 2024
Via
Benzinga
Recap: Nektar Therapeutics Q3 Earnings
↗
November 07, 2023
Via
Benzinga
Earnings Scheduled For March 12, 2025
↗
March 12, 2025
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
↗
February 10, 2025
Via
Benzinga
A Preview Of Nektar Therapeutics's Earnings
↗
November 06, 2023
Via
Benzinga
This Levi Strauss Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday
↗
January 08, 2025
Via
Benzinga
Eczema Drug Developer Nektar Gains Analyst Confidence With 400% Upside Potential
↗
November 04, 2024
Piper Sandler initiates coverage of Nektar Therapeutics, citing REZPEG's Treg-focused action as a potential breakthrough for Alopecia areata treatment.
Via
Benzinga
10 Health Care Stocks Moving In Monday's Pre-Market Session
↗
November 04, 2024
Via
Benzinga
NKTR Stock Earnings: Nektar Therapeutics Misses EPS, Beats Revenue for Q2 2024
↗
August 08, 2024
NKTR stock results show that Nektar Therapeutics missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024.
Via
InvestorPlace
NKTR Stock Earnings: Nektar Therapeutics Meets EPS, Beats Revenue for Q1 2024
↗
May 09, 2024
NKTR stock results show that Nektar Therapeutics met analyst estimates for earnings per share but beat on revenue for the first quarter of 2024.
Via
InvestorPlace
12 Health Care Stocks Moving In Tuesday's After-Market Session
↗
May 07, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
↗
April 30, 2024
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
↗
April 11, 2024
Via
Benzinga
Biotech's Lawsuit With Eli Lilly Might Catalyze Stock
↗
March 29, 2024
Nektar Therapeutics commenced a Phase 2b clinical trial evaluating its lead product candidate rezpegaldesleukin, in patients with severe to very severe alopecia areata, a disease-causing patchy hair...
Via
Talk Markets
Topics
Lawsuit
Why Bitdeer Technologies Shares Are Trading Higher By 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session
↗
March 04, 2024
Shares of Bitdeer Technologies Group (NASDAQ: BTDR) rose sharply during Monday’s session after the company reported preliminary fourth-quarter financial results, announced the successful testing of its...
Via
Benzinga
Earnings Scheduled For March 4, 2024
↗
March 04, 2024
Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is estimated to report earnings for its fourth quarter.
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
↗
January 12, 2024
Via
Benzinga
The One-Minute Market Report - Saturday, Aug. 12
↗
August 12, 2023
In this weekly outlook, I examine the asset classes, sectors, and ETFs that led the market higher, and which market segments bucked the trend by moving lower. Signs that market participation is...
Via
Talk Markets
Topics
ETFs
12 Health Care Stocks Moving In Tuesday's After-Market Session
↗
August 08, 2023
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
↗
August 07, 2023
Via
Benzinga
Why Krystal Biotech Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Monday's Mid-Day Session
↗
August 07, 2023
Gainers Vistagen Therapeutics, Inc. (NASDAQ: VTGN) shares jumped 747.6% to $14.24 after the company announced its Phase 3 PALISADE-2 trial evaluating the efficacy, safety, and tolerability of...
Via
Benzinga
Why Is Nektar Therapeutics Stock Surging Today?
↗
August 07, 2023
Nektar Therapeutics Inc (NASDAQ: NKTR) said its former partner Eli Lilly And Co (NYSE: LLY) had presented "erroneous data" from two Phase 1b studies of its atopic dermatitis drug,
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
↗
August 07, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 10, 2023
↗
May 10, 2023
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
